Anamorelin tablets 50mg/tablet, 100 tablets/box

Medication Safety Tips

Use this product according to its instructions, medical advice, and your health needs. Shipping is arranged after payment once the order meets dispatch requirements.

Contraindications

Warnings and Precautions
· This drug has an inhibitory effect on the sodium channel, so it will inhibit the stimulation of the conduction system. ECG abnormalities may occur after taking this drug (e.g., markedly prolonged PR interval or QRS width, prolonged QT interval). Cardiothoracic ratio, electrolytes, etc. should be measured regularly, and if any abnormalities are found, appropriate measures such as discontinuation should be taken. Particular attention should be paid in the early stages of taking this medicine.
· Hyperglycemia may occur and blood glucose levels and urine glucose should be measured regularly before and during starting this medicine.
· Liver dysfunction may occur. Liver function tests should be performed regularly before and during this medication.

Medication risks

Adverse Reactions
Serious side effects
Stimulation of conduction system inhibition (10.7%)
ECG abnormalities may occur (markedly prolonged PR interval or QRS width, prolonged QT interval, etc.), atrioventricular block, tachycardia, bradycardia, palpitation, hypotension, premature supraventricular beats, etc.
Hyperglycemia (4.3%), increased diabetes (4.3%)
Pay attention to the occurrence of symptoms such as dry mouth and frequent urination, and take appropriate measures such as insulin injection, oral hypoglycemic drugs, and stop taking this medicine if necessary.
Hepatic dysfunction (6.4%)
Hepatic dysfunction with elevated AST, ALT, ALP, gamma-GTP, blood bilirubin, etc. may occur.